Impact Of Low-Frequency HIV-1 Drug Resistance Mutations On Antiretroviral Therapy Outcomes.
Rachel BurdorfShuntai ZhouClaire AmonNathan LongCollin S HillLily AdamsGerald TeghaMaganizo B ChagomeranaAllan JumbeMadalitso MaliwichiShaphil WallieYijia LiRonald SwanstromMina C HosseinipourPublished in: The Journal of infectious diseases (2024)
Using accurate NGS for DRM detection may benefit an additional 10% of the patients by identifying low-frequency K103N mutations.
Keyphrases
- antiretroviral therapy
- hiv infected
- human immunodeficiency virus
- hiv positive
- end stage renal disease
- hiv aids
- ejection fraction
- newly diagnosed
- chronic kidney disease
- peritoneal dialysis
- hepatitis c virus
- prognostic factors
- type diabetes
- patient reported outcomes
- hiv testing
- metabolic syndrome
- men who have sex with men
- weight loss
- label free
- sensitive detection
- glycemic control